American National Insurance’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-86,545
Closed -$8.59M 330
2019
Q3
$8.59M Hold
86,545
0.46% 68
2019
Q2
$7.99M Hold
86,545
0.43% 73
2019
Q1
$8.16M Hold
86,545
0.43% 72
2018
Q4
$5.55M Hold
86,545
0.32% 97
2018
Q3
$7.75M Hold
86,545
0.38% 78
2018
Q2
$6.87M Hold
86,545
0.34% 90
2018
Q1
$7.72M Hold
86,545
0.39% 78
2017
Q4
$9.03M Sell
86,545
-133,600
-61% -$15.1M 0.45% 65
2017
Q3
$32.1M Hold
220,145
1.69% 4
2017
Q2
$28.6M Hold
220,145
1.56% 7
2017
Q1
$27.4M Hold
220,145
1.52% 7
2016
Q4
$25.5M Hold
220,145
1.48% 8
2016
Q3
$23M Hold
220,145
1.33% 9
2016
Q2
$21.7M Hold
220,145
1.27% 11
2016
Q1
$22M Sell
220,145
-565
-0.3% -$58.2K 1.31% 10
2015
Q4
$26.4M Hold
220,710
1.57% 5
2015
Q3
$23.9M Hold
220,710
1.52% 6
2015
Q2
$25.5M Hold
220,710
1.51% 7
2015
Q1
$25.4M Hold
220,710
1.51% 7
2014
Q4
$24.7M Hold
220,710
1.47% 7
2014
Q3
$20.9M Hold
220,710
1.27% 10
2014
Q2
$19M Hold
220,710
1.15% 12
2014
Q1
$15.4M Hold
220,710
0.99% 16
2013
Q4
$18.6M Hold
220,710
1.2% 12
2013
Q3
$17M Hold
220,710
1.21% 11
2013
Q2
$12.9M Buy
+220,710
New +$13.3M 0.96% 22

Other funds holding CELG

American National Insurance's CELG Position: Q4 2019 in Review

American National Insurance sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 86,545 shares — an estimated $8.59M sold.

American National Insurance first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $32.1M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • American National Insurance reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • American National Insurance sold 86,545 Celgene Corp shares in Q4 2019, an estimated $8.59M.
  • American National Insurance first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • American National Insurance's Celgene Corp position peaked at $32.1M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on American National Insurance's 13F filing for Q4 2019, filed 12 Feb 2020.